Healthcare Medicare premium increase from Alzheimer’s drug to be lowered next year Healthcare / 3 months ago by Joseph Choi 05/27/22 4:30 PM ET
Policy Biogen CEO stepping down after Medicare decision on Alzheimer’s drug Policy / 4 months ago by Joseph Choi 05/03/22 10:03 AM ET
Healthcare Medicare finalizes decision to limit coverage of controversial Alzheimer’s drug to those in clinical trial Healthcare / 4 months ago by Peter Sullivan 04/07/22 5:10 PM ET
Healthcare The driving force behind Medicare Part B’s price increase was blunted—the price hike should be, too Healthcare / 6 months ago by Reps. Joe Courtney (D-Conn.) and Angie Craig (D-Minn.), opinion contributors 02/17/22 2:30 PM ET
Healthcare Medicare proposes limited coverage of controversial Alzheimer’s drug Healthcare / 7 months ago by Nathaniel Weixel 01/11/22 4:44 PM ET
Healthcare HHS secretary orders Medicare to ‘reassess’ premium increase driven by Alzheimer’s drug Healthcare / 7 months ago by Peter Sullivan 01/10/22 11:38 AM ET
Healthcare Biogen halves price of controversial Alzheimer’s drug Healthcare / 8 months ago by Nathaniel Weixel 12/20/21 10:48 AM ET
Healthcare Sanders urges Biden to delay Medicare premium hike linked to Alzheimer’s drug Healthcare / 9 months ago by Nathaniel Weixel 12/03/21 4:40 PM ET
Healthcare Medicare premiums to jump in part due to pricey Alzheimer’s drug Healthcare / 9 months ago by Peter Sullivan 11/12/21 6:23 PM ET
Healthcare Biogen investigating death of patient taking Alzheimer’s drug Healthcare / 9 months ago by Nathaniel Weixel 11/10/21 4:16 PM ET
Administration Sales of new Alzheimer’s drug fall short of expectations Administration / 10 months ago by Justine Coleman 10/21/21 10:30 AM ET
Healthcare House Democrats ramp up probe of FDA approval of Alzheimer’s drug Healthcare / 12 months ago by Nathaniel Weixel 09/02/21 1:33 PM ET
Healthcare Cleveland Clinic, Mount Sinai not administering new Alzheimer’s drug Healthcare / 1 year ago by Justine Coleman 07/15/21 10:47 AM ET
Healthcare FDA asks for federal investigation of Alzheimer’s drug approval Healthcare / 1 year ago by Nathaniel Weixel 07/09/21 1:48 PM ET
Healthcare House panels launch investigation into controversial Alzheimer’s drug Healthcare / 1 year ago by Peter Sullivan 06/25/21 5:08 PM ET
Healthcare Former FDA adviser: ‘No good evidence’ that approved Alzheimer’s treatment works Healthcare / 1 year ago by Joseph Choi 06/21/21 4:01 PM ET
